Biosyent Inc

XTSX:RX

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RX's stock price target?

Price Target

9.18 CAD

According to Wall Street analysts, the average 1-year price target for RX is 9.18 CAD with a low forecast of 9.09 CAD and a high forecast of 9.45 CAD.

What is Biosyent Inc's Revenue forecast?

Projected CAGR

11%

For the last 8 years the compound annual growth rate for Biosyent Inc's revenue is 9%. The projected CAGR for the next 3 years is 11%.

What is Biosyent Inc's Operating Income forecast?

Projected CAGR

-7%

For the last 8 years the compound annual growth rate for Biosyent Inc's operating income is 5%. The projected CAGR for the next 4 years is -7%.

What is Biosyent Inc's Net Income forecast?

Projected CAGR

6%

For the last 8 years the compound annual growth rate for Biosyent Inc's net income is 7%. The projected CAGR for the next 3 years is 6%.